Querfeld C - Search Results

1

Comparison of selective retinoic acid receptor- and retinoic X receptor-mediated efficacy, tolerance, and survival in cutaneous t-cell lymphoma.

Querfeld C, Rosen ST, Guitart J, Rademaker A, Fung BB, Posten W, Kuzel TM. Querfeld C, et al. J Am Acad Dermatol. 2004 Jul;51(1):25-32. doi: 10.1016/j.jaad.2003.11.058. J Am Acad Dermatol. 2004. PMID: 15243520 Clinical Trial.

2

Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia.

Brammer JE, Ballen K, Sokol L, Querfeld C, Nakamura R, Mishra A, McLaughlin EM, Feith D, Azimi N, Waldmann TA, Tagaya Y, Loughran T. Brammer JE, et al. Among authors: querfeld c. Blood. 2023 Oct 12;142(15):1271-1280. doi: 10.1182/blood.2022017643. Blood. 2023. PMID: 37352612 Free PMC article. Clinical Trial.

3

Primary cutaneous lymphomas: a review with current treatment options.

Querfeld C, Guitart J, Kuzel TM, Rosen ST. Querfeld C, et al. Blood Rev. 2003 Sep;17(3):131-42. doi: 10.1016/s0268-960x(03)00004-3. Blood Rev. 2003. PMID: 12818223 Review.

4

Cutaneous T-cell lymphomas: a review with emphasis on new treatment approaches.

Querfeld C, Rosen ST, Kuzel TM, Guitart J. Querfeld C, et al. Semin Cutan Med Surg. 2003 Sep;22(3):150-61. doi: 10.1016/S1085-5629(03)00041-5. Semin Cutan Med Surg. 2003. PMID: 14649582 Review.

5

Cutaneous T-cell lymphoma: a paradigm for biological therapies.

Pichardo DA, Querfeld C, Guitart J, Kuzel TM, Rosen ST. Pichardo DA, et al. Among authors: querfeld c. Leuk Lymphoma. 2004 Sep;45(9):1755-65. doi: 10.1080/10428190410001693560. Leuk Lymphoma. 2004. PMID: 15223633 Review.

6

Successful treatment of recalcitrant, erythroderma-associated pruritus with etanercept.

Querfeld C, Guitart J, Kuzel TM, Rosen S. Querfeld C, et al. Arch Dermatol. 2004 Dec;140(12):1539-40. doi: 10.1001/archderm.140.12.1539. Arch Dermatol. 2004. PMID: 15611443 No abstract available.

7

Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.

Querfeld C, Rosen ST, Kuzel TM, Kirby KA, Roenigk HH Jr, Prinz BM, Guitart J. Querfeld C, et al. Arch Dermatol. 2005 Mar;141(3):305-11. doi: 10.1001/archderm.141.3.305. Arch Dermatol. 2005. PMID: 15781671

8

The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy.

Querfeld C, Rosen ST, Guitart J, Kuzel TM. Querfeld C, et al. Curr Opin Hematol. 2005 Jul;12(4):273-8. doi: 10.1097/01.moh.0000166498.64515.03. Curr Opin Hematol. 2005. PMID: 15928483 Review.

9

Bexarotene in the treatment of cutaneous T-cell lymphoma.

Querfeld C, Nagelli LV, Rosen ST, Kuzel TM, Guitart J. Querfeld C, et al. Expert Opin Pharmacother. 2006 May;7(7):907-15. doi: 10.1517/14656566.7.7.907. Expert Opin Pharmacother. 2006. PMID: 16634713 Review.

10

The selective protein kinase C beta inhibitor enzastaurin induces apoptosis in cutaneous T-cell lymphoma cell lines through the AKT pathway.

Querfeld C, Rizvi MA, Kuzel TM, Guitart J, Rademaker A, Sabharwal SS, Krett NL, Rosen ST. Querfeld C, et al. J Invest Dermatol. 2006 Jul;126(7):1641-7. doi: 10.1038/sj.jid.5700322. Epub 2006 Apr 27. J Invest Dermatol. 2006. PMID: 16645590 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters